BioCatalyst

NVO — NOVO NORDISK A S catalysts

2 verified catalyst event(s) for NOVO NORDISK A S (ticker NVO). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-10-01 — A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants W · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-01
in 11d
ESTIMATED
 READOUT
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Part
Phase 3 · Heart Failure, Systemic Inflammation
 NVO NOVO NORDISK A S Ziltivekimab ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-14
in 3mo
ESTIMATED
 READOUT
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help P
Phase 2 · Overweight, Obesity
 NVO NOVO NORDISK A S NNC0662-0419 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.